Achilles Therapeutics plc (ACHL)
NASDAQ: ACHL · Real-Time Price · USD
1.150
+0.010 (0.88%)
At close: Jan 21, 2025, 4:00 PM
1.160
+0.010 (0.87%)
After-hours: Jan 21, 2025, 5:53 PM EST
Achilles Therapeutics Market Cap
Achilles Therapeutics has a market cap or net worth of $47.27 million as of January 22, 2025. Its market cap has increased by 36.27% in one year.
Market Cap
47.27M
Enterprise Value
-35.17M
1-Year Change
36.27%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since the IPO on March 31, 2021, Achilles Therapeutics's market cap has decreased from $731.19M to $47.27M, a decrease of -93.54%. That is a compound annual growth rate of -51.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 46.85M | - |
| Dec 31, 2024 | 46.85M | 29.23% |
| Dec 29, 2023 | 36.26M | -1.60% |
| Dec 30, 2022 | 36.84M | -81.89% |
| Dec 31, 2021 | 203.42M | -72.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |